Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WK | WORKIVA INC | $4.38B | $78.26 | $99.00 | 26.50% | Strong Buy | 8 | 11.36% | N/A | N/A | -1.37% | |||
| IAC | IAC INC | $2.89B | $36.07 | $48.36 | 34.08% | Strong Buy | 11 | -7.46% | N/A | 0.65% | 0.44% | |||
| KAPA | KAIROS PHARMA LTD | $32.78M | $1.58 | $8.33 | 427.41% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| AIOT | POWERFLEET INC | $701.91M | $5.26 | $10.33 | 96.44% | Strong Buy | 3 | 0.84% | N/A | 7.53% | 3.73% | |||
| CNTX | CONTEXT THERAPEUTICS INC | $72.84M | $0.81 | $5.67 | 597.91% | Strong Buy | 3 | N/A | N/A | -63.76% | -60.39% | |||
| NKTX | NKARTA INC | $139.92M | $1.97 | $13.50 | 585.28% | Strong Buy | 4 | N/A | N/A | -26.94% | -21.49% | |||
| SMLR | SEMLER SCIENTIFIC INC | $420.31M | $28.39 | $85.33 | 200.57% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| FANG | DIAMONDBACK ENERGY INC | $38.94B | $134.53 | $192.56 | 43.14% | Strong Buy | 16 | -0.44% | -3.34% | 12.71% | 6.87% | |||
| PASG | PASSAGE BIO INC | $22.09M | $6.95 | $59.25 | 752.52% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| CEVA | CEVA INC | $586.07M | $24.54 | $34.33 | 39.91% | Strong Buy | 3 | 2.81% | N/A | -0.48% | -0.42% | |||
| DMAC | DIAMEDICA THERAPEUTICS INC | $362.34M | $7.01 | $12.33 | 75.93% | Strong Buy | 3 | N/A | N/A | -64.68% | -55.84% | |||
| KRRO | KORRO BIO INC | $294.40M | $31.35 | $91.17 | 190.80% | Strong Buy | 6 | -22.08% | N/A | -96.37% | -61.48% | |||
| ENTA | ENANTA PHARMACEUTICALS INC | $159.48M | $7.46 | $20.25 | 171.45% | Strong Buy | 4 | 2.05% | N/A | -44.90% | -11.82% | |||
| PRO | PROS HOLDINGS INC | $721.60M | $15.00 | $21.25 | 41.67% | Strong Buy | 4 | 8.31% | N/A | -2.27% | 0.43% | |||
| KYMR | KYMERA THERAPEUTICS INC | $3.38B | $47.28 | $59.00 | 24.79% | Strong Buy | 10 | 4.52% | N/A | -31.59% | -27.13% | |||
| DNUT | KRISPY KREME INC | $532.10M | $3.13 | $4.78 | 52.56% | Strong Buy | 4 | -3.56% | N/A | 2.16% | 0.77% | |||
| CARL | CARLSMED INC | $389.41M | $14.65 | $18.33 | 25.14% | Strong Buy | 3 | N/A | N/A | N/A | -58.13% | |||
| MTSR | METSERA INC | $3.59B | $34.21 | $63.50 | 85.62% | Strong Buy | 4 | N/A | N/A | -88.87% | -62.41% | |||
| SGMT | SAGIMET BIOSCIENCES INC | $206.84M | $6.36 | $28.00 | 340.25% | Strong Buy | 4 | N/A | N/A | -68.34% | -64.73% | |||
| CZR | CAESARS ENTERTAINMENT INC | $5.39B | $25.90 | $39.90 | 54.05% | Strong Buy | 10 | 1.76% | N/A | 5.85% | 0.70% | |||
| MBX | MBX BIOSCIENCES INC | $363.32M | $10.87 | $38.80 | 256.95% | Strong Buy | 5 | N/A | N/A | -26.90% | -25.76% | |||
| ICHR | ICHOR HOLDINGS LTD | $585.97M | $17.07 | $27.25 | 59.64% | Strong Buy | 4 | 5.49% | N/A | 4.55% | 3.21% | |||
| ESTC | ELASTIC NV | $9.38B | $88.31 | $118.35 | 34.02% | Strong Buy | 20 | 10.74% | N/A | 4.10% | 1.58% | |||
| FLD | FOLD HOLDINGS INC | $154.41M | $3.30 | $7.83 | 137.36% | Strong Buy | 3 | -7.32% | N/A | -16.39% | -7.97% | |||
| BNTX | BIONTECH SE | $23.53B | $97.88 | $134.25 | 37.16% | Strong Buy | 8 | -2.93% | N/A | -1.24% | -1.06% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $1.04B | $10.71 | $16.50 | 54.06% | Strong Buy | 6 | N/A | N/A | -46.91% | -43.82% | |||
| SKYW | SKYWEST INC | $4.22B | $104.51 | $129.00 | 23.43% | Strong Buy | 3 | 4.40% | 1.54% | 16.73% | 6.02% | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $65.39M | $1.43 | $5.67 | 296.29% | Strong Buy | 3 | N/A | N/A | -206.60% | -92.54% | |||
| TSHA | TAYSHA GENE THERAPIES INC | $823.84M | $3.02 | $8.71 | 188.54% | Strong Buy | 7 | 1.61% | N/A | -32.35% | -24.14% | |||
| AKRO | AKERO THERAPEUTICS INC | $3.42B | $42.85 | $72.50 | 69.19% | Strong Buy | 4 | N/A | N/A | -24.57% | -23.04% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.60B | $125.22 | $172.50 | 37.76% | Strong Buy | 8 | 5.74% | N/A | N/A | N/A | |||
| MSGS | MADISON SQUARE GARDEN SPORTS CORP | $5.07B | $210.95 | $260.60 | 23.54% | Strong Buy | 5 | 1.04% | N/A | N/A | -1.04% | |||
| UTI | UNIVERSAL TECHNICAL INSTITUTE INC | $1.48B | $27.28 | $37.50 | 37.46% | Strong Buy | 4 | 7.69% | -2.25% | 19.25% | 7.85% | |||
| GFL | GFL ENVIRONMENTAL INC | $17.55B | $46.40 | $57.63 | 24.19% | Strong Buy | 8 | 1.10% | -39.19% | N/A | N/A | |||
| PXLW | PIXELWORKS INC | $53.83M | $10.09 | $13.67 | 35.45% | Strong Buy | 3 | 1.00% | N/A | N/A | -38.52% | |||
| PPTA | PERPETUA RESOURCES CORP | $1.94B | $18.01 | $26.83 | 48.99% | Strong Buy | 3 | N/A | N/A | 1.06% | 1.04% | |||
| ENGN | ENGENE HOLDINGS INC | $305.61M | $5.97 | $20.33 | 240.59% | Strong Buy | 3 | N/A | N/A | -19.74% | -16.14% | |||
| CBIO | CRESCENT BIOPHARMA INC | $169.77M | $12.22 | $25.60 | 109.49% | Strong Buy | 5 | N/A | N/A | -49.78% | -44.03% | |||
| MAZE | MAZE THERAPEUTICS INC | $1.02B | $23.25 | $34.50 | 48.39% | Strong Buy | 4 | N/A | N/A | -34.36% | -29.69% | |||
| CSTL | CASTLE BIOSCIENCES INC | $627.16M | $21.62 | $37.33 | 72.68% | Strong Buy | 3 | -4.05% | N/A | -11.02% | -9.21% | |||
| CCI | CROWN CASTLE INC | $40.75B | $93.57 | $121.58 | 29.94% | Strong Buy | 12 | -6.42% | N/A | N/A | N/A | |||
| CHA | CHAGEE HOLDINGS LTD | $3.04B | $16.55 | $35.43 | 114.05% | Strong Buy | 4 | N/A | N/A | 6.05% | 4.36% | |||
| TYRA | TYRA BIOSCIENCES INC | $656.09M | $12.31 | $32.00 | 159.95% | Strong Buy | 4 | N/A | N/A | -27.46% | -25.81% | |||
| TARA | PROTARA THERAPEUTICS INC | $121.92M | $3.16 | $18.67 | 490.73% | Strong Buy | 3 | N/A | N/A | -28.18% | -25.94% | |||
| JCAP | JEFFERSON CAPITAL INC | $1.03B | $17.75 | $23.40 | 31.83% | Strong Buy | 5 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.